Our Firm is representing numerous Stryker hip recall clients in this litigation, and we look forward to continued progress in the proceeding.
New York, New York (PRWEB) September 13, 2014
Stryker hip lawsuits (http://www.strykerhiprecallclaims.com/) filed in the wake of the 2012 Rejuvenate and ABG II Modular-Neck Hip Stem recall continue to mount in a multicounty litigation underway in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports. According to an updated Case List issued by the Court on September 10th, 2,097 cases are now pending in the proceeding. That represents an increase of 33 filings since the Court issued its August update, when 2,068 claims were reported. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)
“Our Firm is representing numerous Stryker hip recall clients in this litigation, and we look forward to continued progress in the proceeding,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who were allegedly harmed by Stryker’s Rejuvenate and ABG II Modular-Neck Hip Stems.
Stryker Hip Recall Litigation
According to court documents, Stryker lawsuits pending in Bergen County allege that the Rejuvenate and ABG II stems were defectively designed and inadequately tested prior to coming to market. The lawsuits further allege that metal debris generated from fretting and corrosion of the components can result in metallosis, osteolysis, chronic pain and other complications which may result in the need for surgery to remove and replace the device.
In addition to the Stryker hip recall litigation underway in New Jersey, a federal multidistrict litigation involving similar lawsuits has been established in U.S. District Court, District of Minnesota. Just over 1,700 cases have been filed in that proceeding. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, No. 244)
The Stryker hip recall was announced by the U.S. Food & Drug Administration on July 6, 2012, due to a high rate of fretting and corrosion at the modular neck junction. Stryker has warned that this occurrence places recipients of the Rejuvenate and ABG II stems at risk for adverse local tissue reactions, pain and swelling. In addition, the company has recommended medical screening for all patients fitted with the components, even if they have not experienced any symptoms that would suggest a problem with their implant.*
Recipients of Rejuvenate and ABG II hip stems may be entitled to compensation if they experienced serious complications allegedly related to fretting and corrosion of the devices. To learn more about the Stryker hip recall, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP